By Randy Krauss
When I first got involved in clinical operations 20 years ago, I sensed a reluctance and/ or lack of interest across the industry in tracking operational metrics. You might say there was interest in what we did (tracking), but not how well we did it (performance). It struck me as odd that companies immersed in data to determine safety and efficacy would not be interested in using a different data set to support ways to conduct the trial in a more timely, efficient manner. After all, doing this would allow the sponsor to realize revenue faster.